Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FGJT8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,309
Award facts
- Contract value 100% obligated
- $8,308.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $8,308.80 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 Unit Vials, awarded on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, and serves as a critical supplier within the Department of Defense's pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was awarded in November 2025 with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V program is part of a broader $30.3 billion acquisition strategy designed to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and established performance across multiple therapeutic categories, positioning it as a key regional prime vendor contractor supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FGJT8?
SPE2DR26FGJT8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FGJT8 worth?
The government has obligated $8,309 on SPE2DR26FGJT8.
Is contract SPE2DR26FGJT8 an order under another contract?
Yes. SPE2DR26FGJT8 is a delivery order under SPE2DR25D9832, an indefinite delivery contract.
Was contract SPE2DR26FGJT8 competed?
The extent of competition for SPE2DR26FGJT8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award